Cardiovascular Magnetic Resonance in the Management of Cardiac Amyloidosis Current and Future Clinical Applications

被引:0
|
作者
Barison, Andrea [1 ,2 ]
Gueli, Ignazio Alessio [1 ,2 ]
Pizzino, Fausto [3 ]
Grigoratos, Chrysanthos [1 ]
Todiere, Giancarlo [1 ]
机构
[1] CNR Reg Toscana, Dept Cardiol & Cardiovasc Med, Fdn Gabriele Monasterio, Via Moruzzi 1, I-56124 Pisa, Italy
[2] Scuola Super Sant Anna, Piazza Martiri Liberta 33, I-56127 Pisa, Italy
[3] CNR Reg Toscana, Osped Cuore, Fdn Gabriele Monasterio, Via Aurelia Sud, I-54100 Massa, Italy
关键词
Amyloid; Magnetic resonance; Late enhancement; T1; mapping; Extracellular volume; LATE GADOLINIUM ENHANCEMENT; PROGNOSTIC VALUE; DIAGNOSIS; CMR; AL;
D O I
10.1016/j.hfc.2024.03.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
CA is a progressive disease causing extracellular myocardial infiltration by AL or ATTR fibrils. Timely diagnosis and treatment are critical to reverse a poor prognosis. CMR is a key tool in the diagnosis and assessment of CA: cine sequences provide superior morphologic and functional information, while LGE, T1 mapping, and ECV are used for diagnosis, localization, and quantification of myocardial amyloid infiltration and correlated with prognosis. Overall, ECV is considered the best quantitative measure of amyloid burden as it is specific for the extracellular space, while less sensitive to edema. In patients with severe renal impairment, where gadolinium administration is a relative contraindication, noncontrast technique (in particular native T1) may be an alternative.
引用
收藏
页码:295 / 305
页数:11
相关论文
共 50 条
  • [1] Clinical and Cardiovascular Magnetic Resonance Imaging Features of Cardiac Amyloidosis
    Tana, Marco
    Tana, Claudio
    Panarese, Alessandro
    Mantini, Cesare
    Ricci, Fabrizio
    Porreca, Ettore
    [J]. REVIEWS IN CARDIOVASCULAR MEDICINE, 2023, 24 (10)
  • [2] Cardiovascular magnetic resonance in cardiac amyloidosis
    Kwong, RY
    Falk, RH
    [J]. CIRCULATION, 2005, 111 (02) : 122 - 124
  • [3] Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
    Muellerleile, Kai
    Lund, Gunnar K.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (25) : 2932 - 2934
  • [4] Cardiovascular Magnetic Resonance and prognosis in cardiac amyloidosis
    Maceira, Alicia M.
    Prasad, Sanjay K.
    Hawkins, Philip N.
    Roughton, Michael
    Pennell, Dudley J.
    [J]. JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2008, 10 (1)
  • [5] Cardiovascular Magnetic Resonance and prognosis in cardiac amyloidosis
    Alicia M Maceira
    Sanjay K Prasad
    Philip N Hawkins
    Michael Roughton
    Dudley J Pennell
    [J]. Journal of Cardiovascular Magnetic Resonance, 10
  • [6] Cardiovascular magnetic resonance imaging: Current applications and future directions
    Desai, MY
    Lima, JA
    Bluemke, D
    [J]. IMAGING IN BIOLOGICAL RESEARCH, PT B, 2004, 386 : 122 - 148
  • [7] Clinical and cardiac magnetic resonance imaging characteristics of cardiac amyloidosis of cardiac amyloidosis
    Zeng, Lijin
    Chen, Zhibin
    Wu, Jingguo
    Yang, Wen
    Li, Zhenyu
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C219 - C220
  • [8] Current and future role of cardiovascular magnetic resonance in cardiac resynchronization therapy
    Francisco Leyva
    Paul W. X. Foley
    [J]. Heart Failure Reviews, 2011, 16 : 251 - 262
  • [9] Current and future role of cardiovascular magnetic resonance in cardiac resynchronization therapy
    Leyva, Francisco
    Foley, Paul W. X.
    [J]. HEART FAILURE REVIEWS, 2011, 16 (03) : 251 - 262
  • [10] Atrial enhancement by cardiovascular magnetic resonance in cardiac amyloidosis
    Lyne, Jonathan C.
    Petryka, Joanna
    Pennell, Dudley J.
    [J]. EUROPEAN HEART JOURNAL, 2008, 29 (02) : 212 - 212